Segitel
Segitel is a pharmaceutical product marketed by Seginus Cure Pharma. it is a trusted antihypertensive brand powered by Telmisartan 40 mg, an angiotensin II receptor blocker (ARB) known for 24-hour blood pressure control, organ protection, and excellent tolerability. Designed for long-term hypertension management, it offers consistent efficacy with added metabolic benefits, making it a preferred choice in modern cardiovascular care.
With a strong focus on real-world BP control, it is available as monotherapy and in rational fixed-dose combinations to address diverse hypertensive profiles.
Product Range
SEGITEL 40
Telmisartan 40 mg
Indications
Essential hypertension
Hypertension in diabetic patients
Cardiovascular risk reduction
Benefits
Smooth, sustained BP reduction
Improves insulin sensitivity
Suitable for long-term therapy
SEGITEL – AM
Telmisartan 40 mg + Amlodipine 5 mg
Indications
Stage 2 hypertension
Patients uncontrolled on monotherapy
Benefits
Dual mechanism: RAAS blockade + calcium channel inhibition
Faster and stronger BP reduction
Reduced amlodipine-related edema due to telmisartan
SEGITEL – BETA
Telmisartan 40 mg + Bisoprolol 5 mg
Indications
Hypertension with ischemic heart disease
Hypertension with tachycardia or post-MI patients
Benefits
Heart rate control with BP stabilization
Reduces cardiac workload
Ideal for cardio-protective therapy
SEGITEL – LN
Telmisartan 40 mg + Cilnidipine 5 mg
Indications
Hypertension with sympathetic overactivity
Elderly hypertensive patients
Benefits
Dual L- and N-type calcium channel blockade
Less pedal edema
Better renal and vascular protection
Advantages
24-Hour BP Control: Long half-life of telmisartan ensures sustained blood pressure reduction
Cardio-Renal Protection: Helps protect heart, kidneys, and vascular endothelium
Metabolically Neutral: Suitable for patients with diabetes, obesity, and dyslipidemia
Rational Combinations: Tailored combinations for better BP control with fewer pills
Excellent Tolerability: Low incidence of cough and edema compared to other antihypertensives
Why Choose Segitel
Covers complete hypertension spectrum
Aligns with current hypertension treatment guidelines
Offers flexibility to physicians for personalized BP management
Supports long-term cardiovascular outcomes
Use under medical supervision
Monitor blood pressure, renal function, and electrolytes periodically
Caution in patients with severe hepatic or renal impairment
Not recommended during pregnancy
Dose adjustment may be required in elderly patients
This information is intended for educational and promotional purposes only. SEGITEL and its variants should be prescribed and used only under the guidance of a qualified healthcare professional. Individual patient response may vary. Always refer to the prescribing information before use.
Frequently Asked Questions (FAQs)
Yes. Telmisartan is well-studied and suitable for long-term hypertension management.
Yes. it is metabolically neutral and beneficial for diabetic hypertensive patients.
When BP is uncontrolled with monotherapy or in patients with specific cardiovascular needs.
No. Telmisartan does not cause ACE-inhibitor-related cough.
Yes. SEGITEL-LN is particularly suitable due to better tolerability and vascular protection.